ARCHIVES

Talpin To Join NCI

This article is from The Cancer Letter archive.

Vol. 29 No. 26 | June 27, 2003

Download PDF Visit The Full Archive

Related Articles

Letrozole Cuts Risk Of Breast Cancer Recurrence Even After Tamoxifen Use

March 28, 2008

NIH Advisors Suggest Revamping Grant Application Review

June 14, 1996

Should Be Cut First, DCT Board Says

December 4, 1981

Phase III Trial of Talimogene Laherparepvec Meets Response Rate Primary Endpoint

March 29, 2013

Agents Not Indicated In Curative Setting.

August 8, 2008

In Brief: Appropriations Markup Delayed Until September; FCRC Recompetition Draws 94 Requests for RFP

July 31, 1981